Jul 7, 2026 07:43AM
Jun 22, 2026 08:07AM
Jun 16, 2026 07:32AM
May 29, 2026 08:41AM
May 26, 2026 08:25AM
May 12, 2026 08:41AM
May 5, 2026 08:53AM Clearmind Medicine files European patent application for PTSD compounds
Apr 20, 2026 04:03PM
Apr 20, 2026 07:15AM
Apr 14, 2026 07:32AM
Mar 30, 2026 08:32AM
Mar 17, 2026 09:15AM
Mar 13, 2026 07:46AM
Mar 11, 2026 09:08AM Clearmind Medicine advances CMND-100 trial enrollment following positive results
Mar 10, 2026 08:59AM
Mar 4, 2026 07:30AM
Feb 19, 2026 04:15PM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:00AM
Feb 6, 2026 08:02AM Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation
Feb 6, 2026 07:57AM
Jan 14, 2026 08:55AM
Dec 24, 2025 09:15AM
Dec 16, 2025 08:45AM
Dec 5, 2025 05:01PM
Dec 2, 2025 07:57AM
Dec 1, 2025 08:57AM Clearmind Medicine receives safety board approval for alcohol disorder trial
Nov 26, 2025 04:18PM
Nov 25, 2025 07:17AM
Nov 24, 2025 08:51AM
Nov 20, 2025 06:45AM
Nov 20, 2025 06:01AM
Nov 18, 2025 08:57AM
Nov 17, 2025 07:55AM Clearmind Medicine files Israeli patent for depression treatment
Nov 10, 2025 08:07AM
Nov 5, 2025 06:55AM
Oct 31, 2025 07:35AM
Oct 30, 2025 07:55AM
Oct 27, 2025 09:22AM
Oct 21, 2025 07:25AM
Oct 20, 2025 07:42AM SciSparc and Clearmind publish patent application for binge disorders
Sep 19, 2025 04:22PM
Sep 19, 2025 08:20AM
Aug 7, 2025 07:32AM
Jul 30, 2025 08:21AM
Jul 23, 2025 08:55AM
Jul 15, 2025 08:05AM
Jul 3, 2025 08:47AM Clearmind Medicine (CMND) Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center
Jun 30, 2025 09:16AM

425,763 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All